1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cancers Immunotherapy Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Monoclonal Antibodies
        1.2.3 Check Point Inhibitors
        1.2.4 Interferons
        1.2.5 Interleukins
    1.3 Market by Application
        1.3.1 Global Cancers Immunotherapy Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Lung Cancer
        1.3.3 Liver Cancer
        1.3.4 Colorectal Cancer
        1.3.5 Pancreatic Cancer
        1.3.6 Breast Cancer
        1.3.7 Other Cancers
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Cancers Immunotherapy Drugs Market Perspective (2017-2028)
    2.2 Cancers Immunotherapy Drugs Growth Trends by Region
        2.2.1 Cancers Immunotherapy Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Cancers Immunotherapy Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Cancers Immunotherapy Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Cancers Immunotherapy Drugs Market Dynamics
        2.3.1 Cancers Immunotherapy Drugs Industry Trends
        2.3.2 Cancers Immunotherapy Drugs Market Drivers
        2.3.3 Cancers Immunotherapy Drugs Market Challenges
        2.3.4 Cancers Immunotherapy Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Cancers Immunotherapy Drugs Players by Revenue
        3.1.1 Global Top Cancers Immunotherapy Drugs Players by Revenue (2017-2022)
        3.1.2 Global Cancers Immunotherapy Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Cancers Immunotherapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Cancers Immunotherapy Drugs Revenue
    3.4 Global Cancers Immunotherapy Drugs Market Concentration Ratio
        3.4.1 Global Cancers Immunotherapy Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cancers Immunotherapy Drugs Revenue in 2021
    3.5 Cancers Immunotherapy Drugs Key Players Head office and Area Served
    3.6 Key Players Cancers Immunotherapy Drugs Product Solution and Service
    3.7 Date of Enter into Cancers Immunotherapy Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Cancers Immunotherapy Drugs Breakdown Data by Type
    4.1 Global Cancers Immunotherapy Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Cancers Immunotherapy Drugs Forecasted Market Size by Type (2023-2028)
5 Cancers Immunotherapy Drugs Breakdown Data by Application
    5.1 Global Cancers Immunotherapy Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Cancers Immunotherapy Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Cancers Immunotherapy Drugs Market Size (2017-2028)
    6.2 North America Cancers Immunotherapy Drugs Market Size by Type
        6.2.1 North America Cancers Immunotherapy Drugs Market Size by Type (2017-2022)
        6.2.2 North America Cancers Immunotherapy Drugs Market Size by Type (2023-2028)
        6.2.3 North America Cancers Immunotherapy Drugs Market Share by Type (2017-2028)
    6.3 North America Cancers Immunotherapy Drugs Market Size by Application
        6.3.1 North America Cancers Immunotherapy Drugs Market Size by Application (2017-2022)
        6.3.2 North America Cancers Immunotherapy Drugs Market Size by Application (2023-2028)
        6.3.3 North America Cancers Immunotherapy Drugs Market Share by Application (2017-2028)
    6.4 North America Cancers Immunotherapy Drugs Market Size by Country
        6.4.1 North America Cancers Immunotherapy Drugs Market Size by Country (2017-2022)
        6.4.2 North America Cancers Immunotherapy Drugs Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Cancers Immunotherapy Drugs Market Size (2017-2028)
    7.2 Europe Cancers Immunotherapy Drugs Market Size by Type
        7.2.1 Europe Cancers Immunotherapy Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Cancers Immunotherapy Drugs Market Size by Type (2023-2028)
        7.2.3 Europe Cancers Immunotherapy Drugs Market Share by Type (2017-2028)
    7.3 Europe Cancers Immunotherapy Drugs Market Size by Application
        7.3.1 Europe Cancers Immunotherapy Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Cancers Immunotherapy Drugs Market Size by Application (2023-2028)
        7.3.3 Europe Cancers Immunotherapy Drugs Market Share by Application (2017-2028)
    7.4 Europe Cancers Immunotherapy Drugs Market Size by Country
        7.4.1 Europe Cancers Immunotherapy Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Cancers Immunotherapy Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Cancers Immunotherapy Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Cancers Immunotherapy Drugs Market Size by Type
        8.2.1 Asia-Pacific Cancers Immunotherapy Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Cancers Immunotherapy Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Cancers Immunotherapy Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific Cancers Immunotherapy Drugs Market Size by Application
        8.3.1 Asia-Pacific Cancers Immunotherapy Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Cancers Immunotherapy Drugs Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Cancers Immunotherapy Drugs Market Share by Application (2017-2028)
    8.4 Asia-Pacific Cancers Immunotherapy Drugs Market Size by Region
        8.4.1 Asia-Pacific Cancers Immunotherapy Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Cancers Immunotherapy Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Cancers Immunotherapy Drugs Market Size (2017-2028)
    9.2 Latin America Cancers Immunotherapy Drugs Market Size by Type
        9.2.1 Latin America Cancers Immunotherapy Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Cancers Immunotherapy Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America Cancers Immunotherapy Drugs Market Share by Type (2017-2028)
    9.3 Latin America Cancers Immunotherapy Drugs Market Size by Application
        9.3.1 Latin America Cancers Immunotherapy Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Cancers Immunotherapy Drugs Market Size by Application (2023-2028)
        9.3.3 Latin America Cancers Immunotherapy Drugs Market Share by Application (2017-2028)
    9.4 Latin America Cancers Immunotherapy Drugs Market Size by Country
        9.4.1 Latin America Cancers Immunotherapy Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Cancers Immunotherapy Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Cancers Immunotherapy Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Cancers Immunotherapy Drugs Market Size by Type
        10.2.1 Middle East & Africa Cancers Immunotherapy Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Cancers Immunotherapy Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Cancers Immunotherapy Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa Cancers Immunotherapy Drugs Market Size by Application
        10.3.1 Middle East & Africa Cancers Immunotherapy Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Cancers Immunotherapy Drugs Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Cancers Immunotherapy Drugs Market Share by Application (2017-2028)
    10.4 Middle East & Africa Cancers Immunotherapy Drugs Market Size by Country
        10.4.1 Middle East & Africa Cancers Immunotherapy Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Cancers Immunotherapy Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Cancers Immunotherapy Drugs Introduction
        11.1.4 Roche Revenue in Cancers Immunotherapy Drugs Business (2017-2022)
        11.1.5 Roche Recent Developments
    11.2 Pfizer
        11.2.1 Pfizer Company Details
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Cancers Immunotherapy Drugs Introduction
        11.2.4 Pfizer Revenue in Cancers Immunotherapy Drugs Business (2017-2022)
        11.2.5 Pfizer Recent Developments
    11.3 Merck
        11.3.1 Merck Company Details
        11.3.2 Merck Business Overview
        11.3.3 Merck Cancers Immunotherapy Drugs Introduction
        11.3.4 Merck Revenue in Cancers Immunotherapy Drugs Business (2017-2022)
        11.3.5 Merck Recent Developments
    11.4 Novartis
        11.4.1 Novartis Company Details
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Cancers Immunotherapy Drugs Introduction
        11.4.4 Novartis Revenue in Cancers Immunotherapy Drugs Business (2017-2022)
        11.4.5 Novartis Recent Developments
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Details
        11.5.2 Johnson & Johnson Business Overview
        11.5.3 Johnson & Johnson Cancers Immunotherapy Drugs Introduction
        11.5.4 Johnson & Johnson Revenue in Cancers Immunotherapy Drugs Business (2017-2022)
        11.5.5 Johnson & Johnson Recent Developments
    11.6 Sanofi
        11.6.1 Sanofi Company Details
        11.6.2 Sanofi Business Overview
        11.6.3 Sanofi Cancers Immunotherapy Drugs Introduction
        11.6.4 Sanofi Revenue in Cancers Immunotherapy Drugs Business (2017-2022)
        11.6.5 Sanofi Recent Developments
    11.7 GlaxoSmithKline
        11.7.1 GlaxoSmithKline Company Details
        11.7.2 GlaxoSmithKline Business Overview
        11.7.3 GlaxoSmithKline Cancers Immunotherapy Drugs Introduction
        11.7.4 GlaxoSmithKline Revenue in Cancers Immunotherapy Drugs Business (2017-2022)
        11.7.5 GlaxoSmithKline Recent Developments
    11.8 Amgen
        11.8.1 Amgen Company Details
        11.8.2 Amgen Business Overview
        11.8.3 Amgen Cancers Immunotherapy Drugs Introduction
        11.8.4 Amgen Revenue in Cancers Immunotherapy Drugs Business (2017-2022)
        11.8.5 Amgen Recent Developments
    11.9 AbbVie
        11.9.1 AbbVie Company Details
        11.9.2 AbbVie Business Overview
        11.9.3 AbbVie Cancers Immunotherapy Drugs Introduction
        11.9.4 AbbVie Revenue in Cancers Immunotherapy Drugs Business (2017-2022)
        11.9.5 AbbVie Recent Developments
    11.10 Boehringer Ingelheim
        11.10.1 Boehringer Ingelheim Company Details
        11.10.2 Boehringer Ingelheim Business Overview
        11.10.3 Boehringer Ingelheim Cancers Immunotherapy Drugs Introduction
        11.10.4 Boehringer Ingelheim Revenue in Cancers Immunotherapy Drugs Business (2017-2022)
        11.10.5 Boehringer Ingelheim Recent Developments
    11.11 AstraZeneca
        11.11.1 AstraZeneca Company Details
        11.11.2 AstraZeneca Business Overview
        11.11.3 AstraZeneca Cancers Immunotherapy Drugs Introduction
        11.11.4 AstraZeneca Revenue in Cancers Immunotherapy Drugs Business (2017-2022)
        11.11.5 AstraZeneca Recent Developments
    11.12 Immatics Biotechnologies
        11.12.1 Immatics Biotechnologies Company Details
        11.12.2 Immatics Biotechnologies Business Overview
        11.12.3 Immatics Biotechnologies Cancers Immunotherapy Drugs Introduction
        11.12.4 Immatics Biotechnologies Revenue in Cancers Immunotherapy Drugs Business (2017-2022)
        11.12.5 Immatics Biotechnologies Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Cancers Immunotherapy Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Monoclonal Antibodies
    Table 3. Key Players of Check Point Inhibitors
    Table 4. Key Players of Interferons
    Table 5. Key Players of Interleukins
    Table 6. Global Cancers Immunotherapy Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Cancers Immunotherapy Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Cancers Immunotherapy Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Cancers Immunotherapy Drugs Market Share by Region (2017-2022)
    Table 10. Global Cancers Immunotherapy Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Cancers Immunotherapy Drugs Market Share by Region (2023-2028)
    Table 12. Cancers Immunotherapy Drugs Market Trends
    Table 13. Cancers Immunotherapy Drugs Market Drivers
    Table 14. Cancers Immunotherapy Drugs Market Challenges
    Table 15. Cancers Immunotherapy Drugs Market Restraints
    Table 16. Global Cancers Immunotherapy Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Cancers Immunotherapy Drugs Revenue Share by Players (2017-2022)
    Table 18. Global Top Cancers Immunotherapy Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancers Immunotherapy Drugs as of 2021)
    Table 19. Ranking of Global Top Cancers Immunotherapy Drugs Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Cancers Immunotherapy Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Cancers Immunotherapy Drugs Product Solution and Service
    Table 23. Date of Enter into Cancers Immunotherapy Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Cancers Immunotherapy Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Cancers Immunotherapy Drugs Revenue Market Share by Type (2017-2022)
    Table 27. Global Cancers Immunotherapy Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Cancers Immunotherapy Drugs Revenue Market Share by Type (2023-2028)
    Table 29. Global Cancers Immunotherapy Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Cancers Immunotherapy Drugs Revenue Share by Application (2017-2022)
    Table 31. Global Cancers Immunotherapy Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Cancers Immunotherapy Drugs Revenue Share by Application (2023-2028)
    Table 33. North America Cancers Immunotherapy Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Cancers Immunotherapy Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Cancers Immunotherapy Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Cancers Immunotherapy Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Cancers Immunotherapy Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Cancers Immunotherapy Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Cancers Immunotherapy Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Cancers Immunotherapy Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Cancers Immunotherapy Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Cancers Immunotherapy Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Cancers Immunotherapy Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Cancers Immunotherapy Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Cancers Immunotherapy Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Cancers Immunotherapy Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Cancers Immunotherapy Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Cancers Immunotherapy Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Cancers Immunotherapy Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Cancers Immunotherapy Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Cancers Immunotherapy Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Cancers Immunotherapy Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Cancers Immunotherapy Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Cancers Immunotherapy Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Cancers Immunotherapy Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Cancers Immunotherapy Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Cancers Immunotherapy Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Cancers Immunotherapy Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Cancers Immunotherapy Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Cancers Immunotherapy Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Cancers Immunotherapy Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Cancers Immunotherapy Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Roche Company Details
    Table 64. Roche Business Overview
    Table 65. Roche Cancers Immunotherapy Drugs Product
    Table 66. Roche Revenue in Cancers Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 67. Roche Recent Developments
    Table 68. Pfizer Company Details
    Table 69. Pfizer Business Overview
    Table 70. Pfizer Cancers Immunotherapy Drugs Product
    Table 71. Pfizer Revenue in Cancers Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 72. Pfizer Recent Developments
    Table 73. Merck Company Details
    Table 74. Merck Business Overview
    Table 75. Merck Cancers Immunotherapy Drugs Product
    Table 76. Merck Revenue in Cancers Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 77. Merck Recent Developments
    Table 78. Novartis Company Details
    Table 79. Novartis Business Overview
    Table 80. Novartis Cancers Immunotherapy Drugs Product
    Table 81. Novartis Revenue in Cancers Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 82. Novartis Recent Developments
    Table 83. Johnson & Johnson Company Details
    Table 84. Johnson & Johnson Business Overview
    Table 85. Johnson & Johnson Cancers Immunotherapy Drugs Product
    Table 86. Johnson & Johnson Revenue in Cancers Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 87. Johnson & Johnson Recent Developments
    Table 88. Sanofi Company Details
    Table 89. Sanofi Business Overview
    Table 90. Sanofi Cancers Immunotherapy Drugs Product
    Table 91. Sanofi Revenue in Cancers Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 92. Sanofi Recent Developments
    Table 93. GlaxoSmithKline Company Details
    Table 94. GlaxoSmithKline Business Overview
    Table 95. GlaxoSmithKline Cancers Immunotherapy Drugs Product
    Table 96. GlaxoSmithKline Revenue in Cancers Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 97. GlaxoSmithKline Recent Developments
    Table 98. Amgen Company Details
    Table 99. Amgen Business Overview
    Table 100. Amgen Cancers Immunotherapy Drugs Product
    Table 101. Amgen Revenue in Cancers Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 102. Amgen Recent Developments
    Table 103. AbbVie Company Details
    Table 104. AbbVie Business Overview
    Table 105. AbbVie Cancers Immunotherapy Drugs Product
    Table 106. AbbVie Revenue in Cancers Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 107. AbbVie Recent Developments
    Table 108. Boehringer Ingelheim Company Details
    Table 109. Boehringer Ingelheim Business Overview
    Table 110. Boehringer Ingelheim Cancers Immunotherapy Drugs Product
    Table 111. Boehringer Ingelheim Revenue in Cancers Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 112. Boehringer Ingelheim Recent Developments
    Table 113. AstraZeneca Company Details
    Table 114. AstraZeneca Business Overview
    Table 115. AstraZeneca Cancers Immunotherapy Drugs Product
    Table 116. AstraZeneca Revenue in Cancers Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 117. AstraZeneca Recent Developments
    Table 118. Immatics Biotechnologies Company Details
    Table 119. Immatics Biotechnologies Business Overview
    Table 120. Immatics Biotechnologies Cancers Immunotherapy Drugs Product
    Table 121. Immatics Biotechnologies Revenue in Cancers Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 122. Immatics Biotechnologies Recent Developments
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancers Immunotherapy Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Monoclonal Antibodies Features
    Figure 3. Check Point Inhibitors Features
    Figure 4. Interferons Features
    Figure 5. Interleukins Features
    Figure 6. Global Cancers Immunotherapy Drugs Market Share by Application: 2021 VS 2028
    Figure 7. Lung Cancer Case Studies
    Figure 8. Liver Cancer Case Studies
    Figure 9. Colorectal Cancer Case Studies
    Figure 10. Pancreatic Cancer Case Studies
    Figure 11. Breast Cancer Case Studies
    Figure 12. Other Cancers Case Studies
    Figure 13. Cancers Immunotherapy Drugs Report Years Considered
    Figure 14. Global Cancers Immunotherapy Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Cancers Immunotherapy Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Cancers Immunotherapy Drugs Market Share by Region: 2021 VS 2028
    Figure 17. Global Cancers Immunotherapy Drugs Market Share by Players in 2021
    Figure 18. Global Top Cancers Immunotherapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancers Immunotherapy Drugs as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Cancers Immunotherapy Drugs Revenue in 2021
    Figure 20. North America Cancers Immunotherapy Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. North America Cancers Immunotherapy Drugs Market Size Market Share by Type (2017-2028)
    Figure 22. North America Cancers Immunotherapy Drugs Market Size Market Share by Application (2017-2028)
    Figure 23. North America Cancers Immunotherapy Drugs Market Size Share by Country (2017-2028)
    Figure 24. United States Cancers Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Cancers Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Cancers Immunotherapy Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 27. Europe Cancers Immunotherapy Drugs Market Size Market Share by Type (2017-2028)
    Figure 28. Europe Cancers Immunotherapy Drugs Market Size Market Share by Application (2017-2028)
    Figure 29. Europe Cancers Immunotherapy Drugs Market Size Share by Country (2017-2028)
    Figure 30. Germany Cancers Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. France Cancers Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. U.K. Cancers Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Italy Cancers Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Russia Cancers Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Nordic Countries Cancers Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Cancers Immunotherapy Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 37. Asia Pacific Cancers Immunotherapy Drugs Market Size Market Share by Type (2017-2028)
    Figure 38. Asia Pacific Cancers Immunotherapy Drugs Market Size Market Share by Application (2017-2028)
    Figure 39. Asia Pacific Cancers Immunotherapy Drugs Market Size Share by Region (2017-2028)
    Figure 40. China Cancers Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Japan Cancers Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. South Korea Cancers Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Southeast Asia Cancers Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. India Cancers Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Australia Cancers Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 46. Latin America Cancers Immunotherapy Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Latin America Cancers Immunotherapy Drugs Market Size Market Share by Type (2017-2028)
    Figure 48. Latin America Cancers Immunotherapy Drugs Market Size Market Share by Application (2017-2028)
    Figure 49. Latin America Cancers Immunotherapy Drugs Market Size Share by Country (2017-2028)
    Figure 50. Mexico Cancers Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Brazil Cancers Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Cancers Immunotherapy Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 53. Middle East and Africa Cancers Immunotherapy Drugs Market Size Market Share by Type (2017-2028)
    Figure 54. Middle East and Africa Cancers Immunotherapy Drugs Market Size Market Share by Application (2017-2028)
    Figure 55. Middle East and Africa Cancers Immunotherapy Drugs Market Size Share by Country (2017-2028)
    Figure 56. Turkey Cancers Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Cancers Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. UAE Cancers Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. Roche Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2017-2022)
    Figure 60. Pfizer Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2017-2022)
    Figure 61. Merck Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2017-2022)
    Figure 62. Novartis Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2017-2022)
    Figure 63. Johnson & Johnson Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2017-2022)
    Figure 64. Sanofi Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2017-2022)
    Figure 65. GlaxoSmithKline Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2017-2022)
    Figure 66. Amgen Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2017-2022)
    Figure 67. AbbVie Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2017-2022)
    Figure 68. Boehringer Ingelheim Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2017-2022)
    Figure 69. AstraZeneca Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2017-2022)
    Figure 70. Immatics Biotechnologies Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2017-2022)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed